About Inma Cobos
Inma Cobos is a physician scientist recently recruited to Stanford in the Department of Pathology. She is a neuropathologist and neuroscientist with expertise in neurodegeneration.
Inma received her medical and doctoral degrees from the University of Murcia in Spain and completed post-doctoral training in Developmental Neurobiology at the University of California, San Francisco. She then pursued a clinical residency and fellowship in Anatomic Pathology and Neuropathology at Massachusetts General Hospital, Harvard Medical School. Before joining Stanford, she was an Assistant Professor in the Department of Pathology and Neuropathology at the UCLA David Geffen School of Medicine.
Her research program combines her background in diagnostic neuropathology, knowledge of developmental neuroscience, and state-of-the-art cellular and molecular technologies to advance the understanding of Alzheimer’s disease and related dementias. Her work is supported by the NIH National Institute of Aging (R01), the Alzheimer’s Association, and BrightFocus. She recently received the Ben Barres Early Career Acceleration Award from the Chan Zuckerberg Initiative (CZI).
Meet the team
During his PhD, Marcos studied the oxytocin and vasopressin circuits that modulate social behavior in rodents. In the Cobos lab, Marcos is developing new methods to profile the transcriptomes of single cells from Alzheimer’s disease brains. He is particularly interested in multi-omics, spatial transcriptomics, and bioinformatics as tools to understand the contributions of distinct cell types to Alzheimer’s disease.
Yueqiang (Edgar) Xue, LSRP
B.Sc. in Basic Medicine from the Peking University Health Science Center
Ph.D. in Biochemistry and Molecular Biology from the Peking Union Medical College
Edgar graduated from the Peking University Health Science Center with a B.Sc. in Basic Medicine, and the Peking Union Medical College with a Ph.D. in Biochemistry and Molecular Biology. He joined the Cobos lab in 2015 and is currently using advanced histological techniques in human brain tissue to map gene expression changes in Alzheimer’s disease. Edgar also helps with the daily activities of the laboratory including lab maintenance, managing databases and providing general lab support.
"We aim to identify the earliest pathogenic mechanisms, understand the progression of pathology, uncover neuroprotective pathways, and identify targetable molecules and pathways.
300 Pasteur Drive
School of Medicine
The Department of Pathology
Lane Building, L235
Stanford CA, 94305